Global Bio-Chem FY26 H1 net loss widens to HK$206.86 million; revenue falls 15.4% to HK$1 billion

• Global Bio-Chem posted a net loss of HK$206.86 million, widening from HK$154.73 million a year earlier.
• Revenue fell 15.4% to HK$1 billion, while gross profit dropped to HK$2.92 million from HK$161.2 million.
• Finance costs narrowed 53.1% to HK$87.69 million, helped by the absence of convertible-bond imputed interest.
• Amino acids swung to a gross loss of HK$8.9 million on 24.6% lower sales volume of 141,000 MT; segment revenue slid to HK$751.54 million.
• Management flagged EU anti-dumping duties and US tariff measures; it is upgrading boiler facilities and advancing a Coenzyme Q10 project.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Global Bio-Chem Technology Group Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260828-12305674), on August 28, 2026, and is solely responsible for the information contained therein.